0001140361-18-024775.txt : 20180518 0001140361-18-024775.hdr.sgml : 20180518 20180518191400 ACCESSION NUMBER: 0001140361-18-024775 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180115 FILED AS OF DATE: 20180518 DATE AS OF CHANGE: 20180518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hosseinion Warren CENTRAL INDEX KEY: 0001438327 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37392 FILM NUMBER: 18848115 MAIL ADDRESS: STREET 1: C/O 1668 S. GARFIELD AVENUE STREET 2: 2ND FLOOR CITY: ALHAMBRA STATE: CA ZIP: 91801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apollo Medical Holdings, Inc. CENTRAL INDEX KEY: 0001083446 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 870042699 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 700 NORTH BRAND BLVD., STREET 2: SUITE 1400 CITY: GLENDALE STATE: CA ZIP: 91203 BUSINESS PHONE: 818-839-5200 MAIL ADDRESS: STREET 1: 700 NORTH BRAND BLVD., STREET 2: SUITE 1400 CITY: GLENDALE STATE: CA ZIP: 91203 FORMER COMPANY: FORMER CONFORMED NAME: SICLONE INDUSTRIES INC DATE OF NAME CHANGE: 19990413 4/A 1 doc1.xml FORM 4/A X0306 4/A 2018-01-15 2018-05-18 0 0001083446 Apollo Medical Holdings, Inc. AMEH 0001438327 Hosseinion Warren C/O 1668 S. GARFIELD AVE. 2ND FLOOR ALHAMBRA CA 91801 1 1 0 0 Co-Chief Executive Officer Common Stock 2018-01-15 4 M 0 22476 6.37 A 1034814 D Common Stock 2018-01-15 4 F 0 4953 28.90 D 1029861 D Stock Option 6.37 2018-01-15 4 M 0 22476 0 D 2016-09-14 2021-02-14 Common Stock 22476 71024 D This is a correcting amendment. The acquisition of the Issuer's common stock reported on this Form 4 resulted from the exercise of an option granted by the Issuer's Compensation Committee, a committee of non-employee directors, and is therefore exempt from section 16(b) of the Securities Exchange Act of 1934, as amended (the "Act"), pursuant to rule 16b-3(d)(1) thereunder. The disposition of such common stock reported was made pursuant to a tax withholding right approved by the Compensation Committee in connection with such option at the time it was granted and is therefore also exempt from section 16(b) of the Act pursuant to rule 16b-3(e) thereunder. Warren Hosseinion 2018-05-18